Your browser doesn't support javascript.
loading
Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.
Cho, Hye Rim; Hong, Bora; Kim, Hyeonjin; Park, Chul-Kee; Park, Sung-Hye; Park, Sunghyouk; Choi, Seung Hong.
Afiliación
  • Cho HR; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Hong B; Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea.
  • Kim H; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Park CK; Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea.
  • Park SH; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Park S; Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea.
  • Choi SH; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
Oncotarget ; 7(43): 69606-69615, 2016 Oct 25.
Article en En | MEDLINE | ID: mdl-27626306

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Resistencia a Antineoplásicos / Ensayos Antitumor por Modelo de Xenoinjerto / Bevacizumab / Transaminasas / Isocitrato Deshidrogenasa Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Resistencia a Antineoplásicos / Ensayos Antitumor por Modelo de Xenoinjerto / Bevacizumab / Transaminasas / Isocitrato Deshidrogenasa Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos